A cheap, widely sold amino-acid supplement may have sharpened mental speed in healthy adults. The catch is that the effect showed up in only one age group, and it wasn't the one you'd expect.
Researchers analyzing data from a randomized, placebo-controlled trial found that 2 grams of carnosine a day was linked to better overall cognitive speed and efficiency in adults aged 23 to 35. Adults aged 36 to 50 and 51 to 65 showed few or no significant gains. The paper, published in Neurotherapeutics in 2025, comes from the University of Louisville team behind the NEAT trial.
Before anyone orders a bottle, here is what the study did and didn't show.
The twist: a brain study hiding inside a pollution trial
The cognition result wasn't the point of the original experiment. The parent study, the Nucleophilic Defense Against PM Toxicity (NEAT) trial (NCT03314987), was designed to test whether carnosine could blunt the harmful effects of particulate matter, the fine particles in air pollution. Carnosine is a nucleophilic dipeptide, a type of molecule that can neutralize reactive compounds produced by oxidative stress. That is the rationale for testing it against pollution toxicity.
The cognitive testing was added as a post-hoc secondary outcome. The researchers looked at brain performance after the trial design was set, which matters a great deal for how much weight the finding deserves (more on that below).
How the study worked
- Design: Randomized, placebo-controlled clinical trial
- Intervention: Carnosine capsules, 2 g daily, versus a cornstarch placebo
- Duration: Up to 12 weeks
- Participants: 299 people randomized. Usable cognitive data came from 242 at the first follow-up (about week 6) and 231 at the second (about week 12)
- Age strata: 23–35, 36–50 and 51–65 years
- Cognitive measure: The Cognition test battery, ten individual tests that each engage specific brain systems across a range of domains. Speed, accuracy and efficiency were scored for the whole battery and for each test
- Testing schedule: Baseline before randomization, then about 6 and 12 weeks into supplementation
The population was also notable for what it lacked. The authors describe it as largely free of susceptibility factors or pre-existing conditions. Earlier work suggested carnosine or beta-alanine might help certain elderly or at-risk groups. This trial asked whether it does anything in generally healthy adults.
What they found
When the researchers split participants by age, the youngest group (23–35) stood out:
- Statistically significant improvements in overall speed and efficiency at both follow-up visits
- Significant improvements in seven speed or accuracy scores across the individual tests
- The two older groups showed few or no significant improvements
The authors concluded that carnosine "selectively improved high-level cognitive performance in young individuals."
The paper's abstract doesn't give effect sizes or per-group sample sizes, so this summary can't say how large the improvements were. "Statistically significant" doesn't tell you whether you'd notice a difference in daily life.
Why the age pattern is odd, and why to be skeptical
Most of the earlier excitement around carnosine centered on older or at-risk people, the groups where declining function leaves more room to improve. A benefit confined to the youngest adults runs against that expectation.
There are good reasons for caution:
- It's a post-hoc secondary analysis. The trial wasn't built to answer a cognition question.
- It's a subgroup finding. Slicing a trial into three age bands and testing many outcomes raises the odds of a chance result. The abstract doesn't describe how the authors adjusted for multiple comparisons.
- No mechanism is established. The abstract doesn't explain why younger brains would respond differently.
- It needs confirmation. A trial designed with cognition as the primary outcome, and age effects pre-specified, would be far more convincing.
The result is a hypothesis worth testing, not a recommendation.
Carnosine vs. beta-alanine: what's the difference?
Carnosine is a dipeptide made of two amino acids, beta-alanine and histidine. It is found naturally in muscle and brain tissue, and in meat and fish.
Beta-alanine is one of those two building blocks, and it is the limiting ingredient for making carnosine in muscle. That's why beta-alanine is a staple in sports supplements: taking it raises muscle carnosine. Its best-known side effect is paresthesia, a harmless tingling of the skin, which is why it is often dosed in smaller amounts through the day.
The NEAT trial tested carnosine itself, not beta-alanine. Whether beta-alanine would reproduce any cognitive effect isn't addressed by this study, and raising muscle carnosine isn't the same as raising it in the brain.
What this means for you
The dose tested: 2 g of carnosine per day, for up to 12 weeks. That is the only regimen with data behind this finding. The abstract doesn't specify timing or whether the dose was split, so there's no evidence-based timing advice to give.
Who might reasonably be curious: Healthy adults in roughly the 23–35 range who want to experiment, ideally after checking with a clinician. That is the group where the signal appeared. Even for them, the evidence is preliminary.
Who probably shouldn't expect much: Healthy adults over 35. In this analysis, the 36–50 and 51–65 groups showed few or no significant gains.
Who should skip it or talk to a doctor first: Anyone pregnant or nursing, anyone on medication, and anyone with a chronic condition. The trial population was largely healthy, so it says little about safety or benefit in other groups.
The cheaper alternative: Beta-alanine is generally less expensive and reliably raises muscle carnosine. But it's a different compound, it hasn't been shown here to improve cognition, and you may feel tingling. Treat it as a separate experiment, not a substitute with proven brain benefits.
Realistic expectations: Nothing here suggests carnosine is a "smart pill." The authors themselves frame it as improved performance on a lab test battery in one subgroup.
The bottom line
A randomized trial built to study air pollution produced a surprising side finding. Two grams of carnosine daily for up to 12 weeks was associated with faster, more efficient performance on a cognitive battery in adults aged 23 to 35, with little effect in older groups. It's intriguing, but it comes from a post-hoc subgroup analysis. Until a dedicated trial confirms it, treat it as a lead worth following rather than a reason to change your routine.
